Omeros Corporation (OMER) Stock Grade

About Omeros Corporation's fundamentals

Omeros Corporation is a biotechnology company with a market capitalization of $1.4 billion and a P/E ratio of 7.8, though this valuation metric reflects the company's net loss in its latest annual statement rather than meaningful profitability. The company showed no year-over-year revenue growth and reported a net margin of 0.0%, indicating it is not currently generating profits from its operations. With a return on equity of just 2.8% and no dividend, the company appears to be in an early or transitional stage of development where shareholder returns depend primarily on future business performance rather than current earnings.